The pharmaceutical giant that bought ZymoGenetics said Tuesday it will vacate the Lake Union Steam Plant in 2019.
Bristol-Myers Squibb (NYSE: BMY), which acquired ZymoGenetics for $885 million in 2010, has announced that it will not renew the lease in 2019 of the space in the landmark Steam Plant on Lake Union. The move is part of the New York City-based company's broader research and development overhaul affecting the East and West coasts.
A few of the Steam Plant’s 80 employees will likely…
The pharmaceutical giant that bought ZymoGenetics said Tuesday it will vacate the Lake Union Steam Plant in 2019.
Bristol-Myers Squibb (NYSE: BMY), which acquired ZymoGenetics for $885 million in 2010, has announced that it will not renew the lease in 2019 of the space in the landmark Steam Plant on Lake Union. The move is part of the New York City-based company's broader research and development overhaul affecting the East and West coasts.
A few of the Steam Plant’s 80 employees will likely…